Massachusetts

Back to map

Showing 21-30 of 34 grants

Title Institution Researcher Program Duration Total Award Amount
The T1D Parent Check-In: A Preventative Intervention Massachusetts General Hospital Ellen O’Donnell Improving Lives 01-July-2023 to 01-September-2026 $390.792,17
Understanding common tissue tolerance mechanisms in autoimmunity Massachusetts General Hospital Gary Reynolds Cures 01-September-2025 to 28-February-2027 $150.000,00
Epithelial Immune Sentinels in T1D Autoimmune Kidney Disease Massachusetts General Hospital Maria Agustina Battistone Improving Lives 01-September-2026 to 31-August-2028 $189.099,97
Development and testing of protease-resistant CXCL12 loaded sub 100 micron polymeric microbeads to enable alloislet transplantation without systemic immune suppression in established murine models of type 1 diabetes Massachusetts General Hospital Mark Poznansky Cures 01-February-2026 to 31-January-2028 $599.448,76
Development of a safe and effective islet-targeted nanoplasmid based CXCL12 gene delivery system using cationic nanobubble-mediated sonotransfection to restore and immune protect the residual beta cell mass in T1D Massachusetts General Hospital Mark Poznansky Cures 01-April-2023 to 31-March-2027 $777.168,00
A Nanosensor Embedded Device for Rapid Insulin Measurement Massachusetts Institute of Technology Michael Strano Improving Lives 01-April-2024 to 31-March-2027 $698.927,98
Assessing use of primary and secondary CVD prevention therapies in people with T1D and developing strategies to increase uptake Putnam Associates Thomas Marder Improving Lives 01-August-2026 to 31-July-2027 $615.000,00
Implementing Best Practice Advisories to Reduce Inequities in Technology Use for people with Type 1 Diabetes T1D Exchange, Inc. Nicole Rioles Improving Lives 01-May-2024 to 30-April-2027 $1.995.534,06
A prodrug system for targeted activation of small molecules in beta cells The Brigham and Women’s Hospital, Inc. Amit Choudhary Cures 01-February-2024 to 31-January-2027 $2.250.000,00
Expanding Access to T1D Care through the PEN-Plus Strategy The Brigham and Women’s Hospital, Inc. Gene Bukhman Mission 01-August-2024 to 31-July-2027 $5.999.961,29